| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OCUL | Common Stock | Sale | -$90.8K | -18.3K | -4.11% | $4.95 | 428K | Jan 31, 2024 | Direct | F1, F2, F3 |
| holding | OCUL | Common Stock | 6.5K | Jan 31, 2024 | By spouse |
| Id | Content |
|---|---|
| F1 | Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 30, 2024. The sales do not represent a discretionary trade by the reporting person. |
| F2 | The reporting person's sale of shares of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 6,500 shares, with the reporting person's indirect purchase of 6,500 shares of common stock at a price of $3.81 per share effected August 30, 2023. The reporting person has paid to the Corporation an aggregate amount of $7,401.55, representing the amount of the profit realized in connection with the short-swing transaction. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.82 to $5.06, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) this Form 4. |